Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells
Open Access
- 1 April 2007
- journal article
- Published by Elsevier BV
- Vol. 282 (15), 10922-10934
- https://doi.org/10.1074/jbc.m610157200
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)Critical Reviews in Oncology/Hematology, 2006
- The complex life of simple sphingolipidsEMBO Reports, 2004
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid KindJournal of Biological Chemistry, 2002
- STI571 (Gleevec™) as a paradigm for cancer therapyTrends in Molecular Medicine, 2002
- Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agentsDrug Resistance Updates, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Characteristics of accelerated disease in chronic myelogenous leukemiaCancer, 1988
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973